Pharmacovigilance: An Essential Tool for Drug Safety Monitoring

Authors

  • JasmineJinitha A Department of Computer Science, Loyola College, Chennai, India
  • Rexline SJ Department of Computer Science, Loyola College, Chennai, India

Keywords:

adverse reactions, adverse effects, drugs, pharmacovigilance

Abstract

Pharmacovigilance(PV) is the science and activities relating to the detection , assessment, understanding and prevention of adverse effects. Adverse effects means the abnormal conditions occurs in the body due to the drugs which are consumed by the peoples. The main process of pharmacovigilance is reporting about the safety and quality of the drugs. It makes the treatment for patients as worthy as possible. This process makes the subject of chemical compositions of the drugs worthy and correctly. This is one of the major process in drug industries. The proposed system use an ideal tool for this process is the reporting by means of forms which are available under medical bodies also by means of web applications for pharmacovigilance process. This paper presents the better results in clinical trials. The success or failure of pharmacovigilance activity depends on the reporting of suspected adverse reactions. Reports made by a health professional are an interpretation of information originally provided by a patient who has experienced the actual benefit or harm of a medicine taken.

References

[1] Overview of Pharmacovigilance Research & Reviews: Journal of Pharmacology and Toxicological Studies/ Amarendra KE Research & Reviews: Journal of Pharmacology and Toxicological Studies e-ISSN: 2319-9873

[2] The Safety of Medicines in Public Health Programmes Pharmacovigilance: an essential tool World Health Organization. ISBN 92 4 159391 1

[3] Dr Arvind Mathur, “WHO guidelines on safety monitoring of herbal medicines in pharmacovigilance”,World Health Organisation

[4] World Health Organization. “Pharmacovigilance: Ensuring the safe use of medicines” Oct 2004

[5] GeetaSharma,RahathKumar.”Pharmacovigilance in India and its impact in patient Management”. The Journal of current trends in Diagnosis and Treatment, 2017, 27-33

[6] “The Uppsala monitoring system”, WHO Collaborating Centre for International Drug Monitoring World Health Organization.

[7] Indian journal of pharmacology volume 50(2); mar-apr 2018

[8] Joerg H. Basic Principles of Pharmacovigilance and Data Sources.

[9] SachdevY.“Pharmacovigilance:SafetyMatters”,IndianPharmacology.2008,vol40, Supplement 1,s13-s16

[10] Kumar A. “ Past, Present and future of Pharmacovigilance in India”. Syst Rev Pharm 2011 2(1),55-58

[11] Naranjo CA, Busto U, Sellers EM, Sandor P, Ruis I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin PharmacolTher. 1981;30:239–45.

[12] Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reactions. Am J Hosp Pharm. 1992;49:2229–32.

Downloads

Published

2025-11-25

How to Cite

[1]
A. JasmineJinitha and S. Rexline, “Pharmacovigilance: An Essential Tool for Drug Safety Monitoring”, Int. J. Comp. Sci. Eng., vol. 7, no. 5, pp. 186–190, Nov. 2025.

Issue

Vol. 7 No. 5 (2019): IJCSE Special Issue Mar Edition

Section

Research Article

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors contributing to this journal agree to publish their articles under the Creative Commons Attribution 4.0 International License, allowing third parties to share their work (copy, distribute, transmit) and to adapt it, under the condition that the authors are given credit and that in the event of reuse or distribution, the terms of this license are made clear.